Study findings show that low-risk patients with unfavorable tumor upgrading were more likely to have disease relapse, which occurred in 8.4% of cases and was associated with older age, PSA density ≥ 0.15 ng/mL/cc, and tumors being larger and extending beyond the gland. Here, KLK3 is linked to neoplasm.